Reports and Publications - Special Access to Drugs and Health Products - Health Canada
Health Canada, through its Special Access Programme (SAP), allows doctors to gain access to non-marketed drugs and medical devices that have not yet been approved for sale in Canada.
The Donor Semen Special Access Programme (DSSAP) provides authority for a processor, distributor or importer to release a specific quantity of donor semen to a physician for use in the performance of assisted conception in exceptional cases.
What information can you find here?
This section contains links to reports and publications related to special access to drugs & health products.
Report a problem or mistake on this page
- Date modified: